16h
News Medical on MSNDiabetes medications may help lower COPD flare-up risk, study findsThe study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...
The worst flu season in years is swamping California, prompting a renewed surge in hospitalizations as officials warn the ...
Exposures to silica dust, solvents or heavy metals increase the likelihood of developing various forms of myositis, ...
Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...
20h
News Medical on MSNJPND calls for research to improve health and social care for neurodegenerative diseasesThe EU Joint Programme - Neurodegenerative Disease Research (JPND) initiative launched a transnational call for health and social care research with a focus on the moderate and late stages of ...
We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...
US FDA grants fast track designation to Nektar Therapeutics’ rezpegaldesleukin to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 11, 2025, 16:00 Hrs ...
Children are more likely than adults to get into medical distress when exposed to the cold, said Dr. Jim Getzinger of ...
9m
Hosted on MSNCan you cure congenital heart defect? Expert answers 14 common questions about the birth defectCongenital heart disease or defect is a common type of birth defect that needs medical attention. The exact cause is unclear, ...
16h
Hosted on MSNUnderstanding Disease Progression in Rheumatoid ArthritisUnderstand RA from early to advanced stages. Explore symptoms, treatments, and lifestyle tips to manage rheumatoid arthritis ...
The University of Pittsburgh Medical Center (UPMC), one of the largest hospital systems in the United States, is reinstating ...
CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results